Market Research Report
Global Markets for Diabetes Therapeutics and Diagnostics
|Published by||BCC Research||Product code||124293|
|Published||Content info||155 Pages
|Global Markets for Diabetes Therapeutics and Diagnostics|
|Published: September 20, 2016||Content info: 155 Pages||
The global diabetes market should reach $155 billion by 2021 from $125 billion in 2016 at a compound annual growth rate (CAGR) of 4.4%, from 2016 to 2021.
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
A comprehensive refresher section on diabetes is provided as an appendix.
Paul Evers has been involved in analyzing pharmaceutical and medical markets for 20 years. He is the author of previous BCC Research reports on the diabetes marketplace covering both therapeutic and monitoring aspects.